Literature DB >> 21752904

Decreased infectivity of a neutralization-resistant equine infectious anemia virus variant can be overcome by efficient cell-to-cell spread.

Wuwei Wu1, Derek C Blythe, Hyelee Loyd, Robert H Mealey, Rebecca L Tallmadge, Karin S Dorman, Susan Carpenter.   

Abstract

Two variants of equine infectious anemia virus (EIAV) that differed in sensitivity to broadly neutralizing antibody were tested in direct competition assays. No differences were observed in the growth curves and relative fitness scores of EIAVs of principal neutralizing domain variants of groups 1 (EIAV(PND-1)) and 5 (EIAV(PND-5)), respectively; however, the neutralization-resistant EIAV(PND-5) variant was less infectious in single-round replication assays. Infectious center assays indicated similar rates of cell-to-cell spread, which was approximately 1,000-fold more efficient than cell-free infectivity. These data indicate that efficient cell-to-cell spread can overcome the decreased infectivity that may accompany immune escape and should be considered in studies assessing the relative levels of fitness among lentivirus variants, including HIV-1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21752904      PMCID: PMC3196457          DOI: 10.1128/JVI.05349-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses.

Authors:  Sandra D Taylor; Steven R Leib; Susan Carpenter; Robert H Mealey
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

2.  Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease.

Authors:  Brett A Sponseller; Wendy O Sparks; Yvonne Wannemuehler; Yuxing Li; Amanda K Antons; J Lindsay Oaks; Susan Carpenter
Journal:  Virology       Date:  2007-02-27       Impact factor: 3.616

3.  Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry.

Authors:  Andre J Marozsan; Dawn M Moore; Michael A Lobritz; Erika Fraundorf; Awet Abraha; Jacqueline D Reeves; Eric J Arts
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes.

Authors:  J M Carr; H Hocking; P Li; C J Burrell
Journal:  Virology       Date:  1999-12-20       Impact factor: 3.616

5.  Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody.

Authors:  P Gupta; R Balachandran; M Ho; A Enrico; C Rinaldo
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

6.  Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies.

Authors:  J M Ball; K E Rushlow; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

7.  Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus.

Authors:  R L Tallmadge; M A Brindley; J Salmans; R H Mealey; W Maury; S Carpenter
Journal:  Clin Vaccine Immunol       Date:  2008-04-30

8.  Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.

Authors:  Laryssa Howe; Caroline Leroux; Charles J Issel; Ronald C Montelaro
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

9.  Natural variation in the V3 crown of human immunodeficiency virus type 1 affects replicative fitness and entry inhibitor sensitivity.

Authors:  Michael A Lobritz; Andre J Marozsan; Ryan M Troyer; Eric J Arts
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

10.  Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.

Authors:  Beda Joos; Alexandra Trkola; Marek Fischer; Herbert Kuster; Peter Rusert; Christine Leemann; Jürg Böni; Annette Oxenius; David A Price; Rodney E Phillips; Joseph K Wong; Bernard Hirschel; Rainer Weber; Huldrych F Günthard
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

View more
  8 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Antibody escape kinetics of equine infectious anemia virus infection of horses.

Authors:  Elissa J Schwartz; Seema Nanda; Robert H Mealey
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

3.  Cell-free transmission of human adenovirus by passive mass transfer in cell culture simulated in a computer model.

Authors:  Artur Yakimovich; Heidi Gumpert; Christoph J Burckhardt; Verena A Lütschg; Andreas Jurgeit; Ivo F Sbalzarini; Urs F Greber
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

4.  Stability of the resistance to the thiosemicarbazone derived from 5,6-dimethoxy-1-indanone, a non-nucleoside polymerase inhibitor of bovine viral diarrhea virus.

Authors:  Eliana F Castro; Rodolfo H Campos; Lucía V Cavallaro
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

5.  Antigenic and Biological Characterization of ORF2-6 Variants at Early Times Following PRRSV Infection.

Authors:  Alyssa B Evans; Hyelee Loyd; Jenelle R Dunkelberger; Sarah van Tol; Marcus J Bolton; Karin S Dorman; Jack C M Dekkers; Susan Carpenter
Journal:  Viruses       Date:  2017-05-16       Impact factor: 5.048

6.  Infection of equine monocyte-derived macrophages with an attenuated equine infectious anemia virus (EIAV) strain induces a strong resistance to the infection by a virulent EIAV strain.

Authors:  Jian Ma; Shan-Shan Wang; Yue-Zhi Lin; Hai-Fang Liu; Qiang Liu; Hua-Mian Wei; Xue-Feng Wang; Yu-Hong Wang; Cheng Du; Xian-Gang Kong; Jian-Hua Zhou; Xiaojun Wang
Journal:  Vet Res       Date:  2014-08-09       Impact factor: 3.683

7.  Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus.

Authors:  Elissa J Schwartz; Robert J Smith
Journal:  Vaccines (Basel)       Date:  2014-05-27

Review 8.  Viral fitness: definitions, measurement, and current insights.

Authors:  Andrew R Wargo; Gael Kurath
Journal:  Curr Opin Virol       Date:  2012-09-15       Impact factor: 7.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.